DK1032565T3 - Fremgangsmåde til fremstilling af derivater af taxoid-klassen - Google Patents

Fremgangsmåde til fremstilling af derivater af taxoid-klassen

Info

Publication number
DK1032565T3
DK1032565T3 DK98955658T DK98955658T DK1032565T3 DK 1032565 T3 DK1032565 T3 DK 1032565T3 DK 98955658 T DK98955658 T DK 98955658T DK 98955658 T DK98955658 T DK 98955658T DK 1032565 T3 DK1032565 T3 DK 1032565T3
Authority
DK
Denmark
Prior art keywords
preparation
class derivatives
taxoid class
taxoid
derivatives
Prior art date
Application number
DK98955658T
Other languages
Danish (da)
English (en)
Inventor
Eric Didier
Gilles Oddon
Denis Pauze
Patrick Leon
Didier Riguet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1032565T3 publication Critical patent/DK1032565T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK98955658T 1997-11-18 1998-11-16 Fremgangsmåde til fremstilling af derivater af taxoid-klassen DK1032565T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714442A FR2771092B1 (fr) 1997-11-18 1997-11-18 Procede de preparation de derives de la classe des taxoides
PCT/FR1998/002432 WO1999025704A1 (fr) 1997-11-18 1998-11-16 Procede de preparation de derives de la classe des taxoides

Publications (1)

Publication Number Publication Date
DK1032565T3 true DK1032565T3 (da) 2003-06-02

Family

ID=9513490

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98955658T DK1032565T3 (da) 1997-11-18 1998-11-16 Fremgangsmåde til fremstilling af derivater af taxoid-klassen

Country Status (44)

Country Link
US (1) US5962705A (enEXAMPLES)
EP (1) EP1032565B1 (enEXAMPLES)
JP (1) JP4359386B2 (enEXAMPLES)
KR (1) KR100581656B1 (enEXAMPLES)
CN (1) CN100375744C (enEXAMPLES)
AP (1) AP1198A (enEXAMPLES)
AR (1) AR017639A1 (enEXAMPLES)
AT (1) ATE232855T1 (enEXAMPLES)
AU (1) AU755376B2 (enEXAMPLES)
BG (1) BG64281B1 (enEXAMPLES)
BR (1) BRPI9814658B8 (enEXAMPLES)
CA (1) CA2304833C (enEXAMPLES)
CO (1) CO4771105A1 (enEXAMPLES)
CZ (1) CZ292642B6 (enEXAMPLES)
DE (1) DE69811530T2 (enEXAMPLES)
DK (1) DK1032565T3 (enEXAMPLES)
DZ (1) DZ2653A1 (enEXAMPLES)
EA (1) EA002622B1 (enEXAMPLES)
EE (1) EE04277B1 (enEXAMPLES)
ES (1) ES2192795T3 (enEXAMPLES)
FR (1) FR2771092B1 (enEXAMPLES)
GE (1) GEP20022822B (enEXAMPLES)
HU (1) HU228188B1 (enEXAMPLES)
ID (1) ID24620A (enEXAMPLES)
IL (1) IL135512A (enEXAMPLES)
IN (1) IN191018B (enEXAMPLES)
IS (1) IS2272B (enEXAMPLES)
MA (1) MA24817A1 (enEXAMPLES)
MX (1) MXPA00002244A (enEXAMPLES)
MY (1) MY121031A (enEXAMPLES)
NO (1) NO325664B1 (enEXAMPLES)
NZ (1) NZ504125A (enEXAMPLES)
OA (1) OA11384A (enEXAMPLES)
PL (1) PL191240B1 (enEXAMPLES)
PT (1) PT1032565E (enEXAMPLES)
SI (1) SI1032565T1 (enEXAMPLES)
SK (1) SK283932B6 (enEXAMPLES)
TN (1) TNSN98207A1 (enEXAMPLES)
TR (1) TR200001415T2 (enEXAMPLES)
TW (1) TW518329B (enEXAMPLES)
UA (1) UA56275C2 (enEXAMPLES)
UY (1) UY25256A1 (enEXAMPLES)
WO (1) WO1999025704A1 (enEXAMPLES)
ZA (1) ZA9810511B (enEXAMPLES)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6346543B1 (en) 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2009282413B2 (en) 2008-08-11 2014-07-17 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
EA024186B1 (ru) 2009-10-29 2016-08-31 Авентис Фарма С.А. Применение кабазитаксела в комбинации с преднизоном или преднизолоном для лечения рака простаты
US8791279B2 (en) 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
KR20140018917A (ko) 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. 카바지탁셀의 고상 형태 및 이의 제조 방법
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103012330A (zh) * 2011-09-23 2013-04-03 复旦大学 一种紫杉醇类抗癌药xrp6258的制备方法
CN103012329A (zh) * 2011-09-23 2013-04-03 复旦大学 一种制备紫杉醇类抗癌药Cabazitaxel XRP6258的方法
EP2760848B1 (en) 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
WO2013072766A2 (en) 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
CN103159704B (zh) * 2011-12-12 2015-06-10 上海佰霖国际贸易有限公司 卡巴他赛中间体及卡巴他赛中间体的制备方法
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CN102786502B (zh) * 2012-08-21 2014-05-14 江苏红豆杉生物科技有限公司 一种紫杉烷药物7,10-甲氧基多西他赛的合成方法
CA2889448C (en) 2012-11-09 2021-07-06 Intas Pharmaceuticals Limited Process for the preparation of cabazitaxel and its intermediates
KR101407353B1 (ko) 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103012331A (zh) * 2012-12-28 2013-04-03 北京科莱博医药开发有限责任公司 卡巴他赛及其中间体的制备方法
EP3008047B1 (en) * 2013-06-14 2019-01-09 Hetero Research Foundation Process for cabazitaxel
CN106632158B (zh) * 2013-08-28 2018-11-06 江苏恒瑞医药股份有限公司 7β,10β-二甲氧基-10-去乙酰基浆果赤霉素III的制备方法
CN103450117A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种7,10-二甲氧基紫杉烷化合物的制备方法
KR101490738B1 (ko) 2013-10-15 2015-02-11 (주)한국해양기상기술 플랑크톤 검사장치
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN105121419B (zh) * 2013-12-24 2016-08-03 于跃 Cabazitaxel类抗多药耐药紫杉烷类抗肿瘤化合物及其制备方法
CN104817522A (zh) * 2015-04-01 2015-08-05 江苏红豆杉药业有限公司 一种7,10-二甲氧基-10DabⅢ的合成方法
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927118A (en) * 1973-12-21 1975-12-16 Crown Zellerbach Corp Process for monoetherification of polyhydric benzenes
EP0304244A3 (en) * 1987-08-18 1990-01-10 Takeda Chemical Industries, Ltd. Propanediol derivatives, their production and use
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) * 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
AU2301295A (en) * 1994-04-28 1995-11-29 Allelix Biopharmaceuticals Inc. Guanidino-substituted compounds
IT1274250B (it) * 1995-02-21 1997-07-15 Himont Inc Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis

Also Published As

Publication number Publication date
CN100375744C (zh) 2008-03-19
AU755376B2 (en) 2002-12-12
CO4771105A1 (es) 1999-04-30
TNSN98207A1 (fr) 2005-03-15
DE69811530D1 (de) 2003-03-27
AP2000001816A0 (en) 2000-06-30
UY25256A1 (es) 2001-08-27
NZ504125A (en) 2002-10-25
EA002622B1 (ru) 2002-06-27
BRPI9814658B8 (pt) 2021-05-25
CA2304833A1 (fr) 1999-05-27
BRPI9814658B1 (pt) 2016-07-19
TR200001415T2 (tr) 2001-01-22
IS2272B (is) 2007-07-15
NO20002443D0 (no) 2000-05-11
ID24620A (id) 2000-07-27
UA56275C2 (uk) 2003-05-15
CN1270586A (zh) 2000-10-18
BG104455A (en) 2001-02-28
KR100581656B1 (ko) 2006-05-23
NO20002443L (no) 2000-05-11
SK283932B6 (sk) 2004-05-04
TW518329B (en) 2003-01-21
PL191240B1 (pl) 2006-04-28
HUP0100519A3 (en) 2002-09-30
IL135512A (en) 2004-06-20
CZ292642B6 (cs) 2003-11-12
HU228188B1 (en) 2013-01-28
EP1032565A1 (fr) 2000-09-06
EA200000539A1 (ru) 2000-12-25
BG64281B1 (bg) 2004-08-31
MA24817A1 (fr) 1999-12-31
SK7102000A3 (en) 2000-11-07
PL340579A1 (en) 2001-02-12
KR20010032138A (ko) 2001-04-16
AU1242299A (en) 1999-06-07
OA11384A (fr) 2004-01-27
PT1032565E (pt) 2003-07-31
ZA9810511B (en) 1999-05-25
HUP0100519A1 (hu) 2001-06-28
CZ20001789A3 (cs) 2000-11-15
JP4359386B2 (ja) 2009-11-04
DZ2653A1 (fr) 2003-03-15
EE04277B1 (et) 2004-04-15
SI1032565T1 (en) 2003-06-30
BR9814658A (pt) 2000-10-03
FR2771092B1 (fr) 1999-12-17
EP1032565B1 (fr) 2003-02-19
ATE232855T1 (de) 2003-03-15
CA2304833C (fr) 2007-03-27
MXPA00002244A (es) 2002-04-24
MY121031A (en) 2005-12-30
US5962705A (en) 1999-10-05
DE69811530T2 (de) 2003-10-02
IS5471A (is) 2000-04-26
IN191018B (enEXAMPLES) 2003-09-13
WO1999025704A1 (fr) 1999-05-27
ES2192795T3 (es) 2003-10-16
JP2001523673A (ja) 2001-11-27
AR017639A1 (es) 2001-09-12
NO325664B1 (no) 2008-07-07
AP1198A (en) 2003-08-27
FR2771092A1 (fr) 1999-05-21
GEP20022822B (en) 2002-10-25
EE200000155A (et) 2001-06-15
IL135512A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1001962T3 (da) Fremstilling af avermectinforbindelser
DK1159296T3 (da) Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly)
DK0787729T3 (da) Fremgangsmåde til fremstilling af imidazodiazepinderivater
DK0782982T3 (da) Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater